Assignee
DRACEN PHARMACEUTICALS INC
US·2 granted patents·3 pending applications·0 citations·filing 2020–2021
Top patents by PatentIndex Score
5 records- 0145US2023372294A1Lyophilized composition comprising (s)-isopropyl 2-((s)-2-acetamido-3-(1h-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate for subcutaneous administration and the use thereofDRACEN PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0240US2022332676A1Lyophilized composition comprising (s)-isopropyl 2-((s)-2-acetamido-3-(1h-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate for intravenous administration and the use thereofDRACEN PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0337US2022117938A1Combinaton therapy with a don prodrug and an immune checkpoint inhibitorDRACEN PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0436US12240797B2Method of preparing a DON prodrug from L-glutamic acidDRACEN PHARMACEUTICALS INC·Filed 2020·Granted Mar 4, 2025·0 cites·20 claims
- 0533US11760723B2Method of preparing a DON prodrug from L-pyroglutamic acidDRACEN PHARMACEUTICALS INC·Filed 2020·Granted Sep 19, 2023·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when DRACEN PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →